Ipra-Dime Injection 1gm

About Ipra-Dime Injection 1gm

Ipra-Dime Injection 1gm Uses

• Treating pneumonia and other lower respiratory tract infections
• Treating complicated urinary tract infections
• Treating skin and soft tissue infections caused by susceptible bacteria
• Treating intra abdominal infections including peritonitis
• Treating bacterial meningitis in hospitalized patients
• Treating septicemia caused by susceptible gram negative organisms

Ipra-Dime Injection 1gm Benefits

• Works against a wide range of gram negative bacteria including Pseudomonas aeruginosa
• Reaches high concentrations in blood and tissue fluid within minutes of injection
• Suitable for hospitalized patients who cannot take oral antibiotics
• Often used as first line therapy in febrile neutropenia and serious hospital acquired infections

What Experts Say

Ceftazidime belongs to the third generation cephalosporin family and works by binding to penicillin binding proteins on the bacterial cell wall. This action blocks cell wall synthesis and causes the bacteria to rupture and die. Its molecular structure gives it strong activity against Pseudomonas aeruginosa, a bacterium that resists many other antibiotics.

Pharmacologists note that ceftazidime is eliminated largely unchanged through the kidneys, so the dose must be adjusted in patients with reduced kidney function. Clinicians often start this injection empirically in seriously ill hospitalized patients before culture results return, then narrow therapy once the exact organism and its sensitivity pattern are confirmed.

Experts caution that patients with a known penicillin allergy may also react to cephalosporins because of a shared beta lactam ring structure. High doses in patients with poor kidney function have been linked to seizures, so dosing is carefully calculated by body weight and renal function to keep therapy both effective and safe.

Drug Class

• Third Generation Cephalosporin Antibiotic

Ipra-Dime Injection 1gm formula

• Ceftazidime

Available forms

• Injection

How to use Ipra-Dime Injection 1gm?

• Administer only by a doctor or trained healthcare professional in a hospital or clinic setting
• Give by slow intravenous injection, intravenous infusion, or deep intramuscular injection as directed
• Reconstitute the vial with the diluent provided or as instructed by the pharmacist immediately before use
• Complete the full course even if symptoms improve after a few doses
• Inform the doctor about any known allergy to penicillin or other cephalosporins before the first dose

Drug Interactions

• Aminoglycosides: Combined use with drugs such as gentamicin raises the risk of kidney damage and requires kidney function monitoring.
• Furosemide: This and other loop diuretics can add to the kidney toxicity risk when used alongside ceftazidime.
• Warfarin: Ceftazidime may enhance the blood thinning effect, so clotting levels should be checked more closely during treatment.
• Probenecid: This medicine can raise ceftazidime blood levels by slowing its removal through the kidneys.

Risks and warnings

• Allergic Reaction: Stop use and seek emergency care if rash, swelling of the face or throat, or difficulty breathing occurs after the injection.
• Kidney Impairment: Dose adjustment is required in patients with reduced kidney function to avoid drug accumulation and toxicity.
• Seizure Risk: High doses in patients with kidney impairment have been linked to confusion, tremors, and seizures.
• Superinfection: Prolonged use may allow overgrowth of resistant bacteria or fungi, including Clostridioides difficile associated diarrhea.
• Pregnancy And Breastfeeding: Use only if the treating doctor considers it clearly necessary, since ceftazidime crosses into breast milk in small amounts.

Ipra-Dime Injection 1gm Side Effects

• Pain, redness, or swelling at the injection site
• Nausea, vomiting, or diarrhea
• Skin rash or itching
• Headache
• Elevated liver enzymes on blood tests
• Severe watery or bloody diarrhea from Clostridioides difficile infection
• Signs of a severe allergic reaction such as facial swelling or breathing difficulty
• Unusual bleeding or bruising
• Seizures in patients with kidney impairment given high doses

Storage Conditions

• Store the unopened vial at temperatures between 15°C and 25°C away from direct sunlight
• Refrigerate the reconstituted solution at 2°C to 8°C if not used immediately
• Discard the reconstituted solution if not used within the time stated on the pack insert
• Keep the vial in its outer carton until the moment of use
• Keep out of reach of children